OPKO Health IncNASDAQ:OPK
- LAST PRICE1.4700
- TODAY'S CHANGE (%)0.0200 (1.3793%)
- Bid / Lots1.4500/ 20
- Ask / Lots1.4800/ 10
- Open / Previous Close1.4400 / 1.4500
- Day Range
- 52 Week Range
- Volume1,759,087
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | OPK |
|---|---|---|
| 09:32 ET | 90397 | 1.4393 |
| 09:34 ET | 28014 | 1.45 |
| 09:36 ET | 63274 | 1.446 |
| 09:38 ET | 1200 | 1.4414 |
| 09:41 ET | 700 | 1.4444 |
| 09:43 ET | 411 | 1.445 |
| 09:45 ET | 600 | 1.4495 |
| 09:48 ET | 500 | 1.44 |
| 09:50 ET | 1197 | 1.445 |
| 09:52 ET | 164 | 1.445 |
| 09:54 ET | 1200 | 1.4464 |
| 09:56 ET | 6200 | 1.445 |
| 09:57 ET | 2864 | 1.445 |
| 09:59 ET | 800 | 1.4445 |
| 10:01 ET | 100 | 1.445 |
| 10:03 ET | 300 | 1.44 |
| 10:06 ET | 150575 | 1.45 |
| 10:08 ET | 82120 | 1.455 |
| 10:12 ET | 2000 | 1.455 |
| 10:14 ET | 2760 | 1.455 |
| 10:15 ET | 44960 | 1.445 |
| 10:17 ET | 2560 | 1.45 |
| 10:19 ET | 4656 | 1.45 |
| 10:21 ET | 29342 | 1.449 |
| 10:24 ET | 1998 | 1.45 |
| 10:26 ET | 1100 | 1.447 |
| 10:28 ET | 108 | 1.445 |
| 10:30 ET | 74696 | 1.44 |
| 10:32 ET | 26803 | 1.445 |
| 10:35 ET | 97011 | 1.4451 |
| 10:37 ET | 537 | 1.445 |
| 10:39 ET | 122 | 1.445 |
| 10:42 ET | 914 | 1.4448 |
| 10:44 ET | 526 | 1.445 |
| 10:46 ET | 16200 | 1.445 |
| 10:48 ET | 75084 | 1.445 |
| 10:50 ET | 42088 | 1.455 |
| 10:51 ET | 1100 | 1.455 |
| 10:53 ET | 400 | 1.455 |
| 10:55 ET | 100 | 1.455 |
| 10:57 ET | 550 | 1.455 |
| 11:00 ET | 839 | 1.455 |
| 11:02 ET | 622 | 1.455 |
| 11:06 ET | 100 | 1.455 |
| 11:08 ET | 2301 | 1.455 |
| 11:13 ET | 300 | 1.45 |
| 11:15 ET | 11600 | 1.455 |
| 11:18 ET | 14465 | 1.445 |
| 11:20 ET | 500 | 1.4452 |
| 11:22 ET | 300 | 1.44 |
| 11:24 ET | 1500 | 1.445 |
| 11:26 ET | 425 | 1.445 |
| 11:27 ET | 1109 | 1.44 |
| 11:29 ET | 400 | 1.445 |
| 11:31 ET | 700 | 1.44 |
| 11:33 ET | 600 | 1.4421 |
| 11:36 ET | 600 | 1.44 |
| 11:38 ET | 1617 | 1.445 |
| 11:40 ET | 700 | 1.44 |
| 11:42 ET | 1000 | 1.44 |
| 11:44 ET | 3000 | 1.445 |
| 11:45 ET | 49702 | 1.445 |
| 11:47 ET | 44735 | 1.455 |
| 11:49 ET | 1500 | 1.455 |
| 11:51 ET | 10410 | 1.455 |
| 11:54 ET | 12460 | 1.46 |
| 11:56 ET | 18725 | 1.465 |
| 11:58 ET | 700 | 1.465 |
| 12:00 ET | 2515 | 1.465 |
| 12:02 ET | 4087 | 1.465 |
| 12:03 ET | 609 | 1.465 |
| 12:05 ET | 100 | 1.465 |
| 12:07 ET | 300 | 1.465 |
| 12:12 ET | 300 | 1.46 |
| 12:14 ET | 700 | 1.465 |
| 12:16 ET | 100 | 1.465 |
| 12:18 ET | 1300 | 1.46 |
| 12:20 ET | 100 | 1.465 |
| 12:21 ET | 200 | 1.46 |
| 12:23 ET | 200 | 1.46 |
| 12:25 ET | 100 | 1.46 |
| 12:27 ET | 300 | 1.465 |
| 12:30 ET | 300 | 1.465 |
| 12:32 ET | 1899 | 1.465 |
| 12:34 ET | 2778 | 1.463 |
| 12:36 ET | 900 | 1.465 |
| 12:38 ET | 100 | 1.46 |
| 12:39 ET | 2325 | 1.465 |
| 12:41 ET | 500 | 1.46 |
| 12:43 ET | 700 | 1.4605 |
| 12:45 ET | 670 | 1.465 |
| 12:48 ET | 200 | 1.46 |
| 12:50 ET | 1155 | 1.465 |
| 12:52 ET | 750 | 1.46 |
| 12:54 ET | 500 | 1.46 |
| 12:56 ET | 1000 | 1.46 |
| 12:57 ET | 600 | 1.465 |
| 12:59 ET | 1200 | 1.465 |
| 01:01 ET | 400 | 1.46 |
| 01:03 ET | 600 | 1.46 |
| 01:06 ET | 6450 | 1.465 |
| 01:08 ET | 1800 | 1.465 |
| 01:10 ET | 4934 | 1.465 |
| 01:12 ET | 2803 | 1.4621 |
| 01:14 ET | 7260 | 1.46 |
| 01:17 ET | 529 | 1.46 |
| 01:19 ET | 13700 | 1.465 |
| 01:21 ET | 57452 | 1.46 |
| 01:24 ET | 950 | 1.46 |
| 01:26 ET | 200 | 1.465 |
| 01:28 ET | 100 | 1.465 |
| 01:30 ET | 650 | 1.465 |
| 01:32 ET | 400 | 1.465 |
| 01:35 ET | 600 | 1.465 |
| 01:37 ET | 700 | 1.46 |
| 01:39 ET | 906 | 1.4699 |
| 01:42 ET | 501 | 1.46 |
| 01:44 ET | 400 | 1.46 |
| 01:46 ET | 41158 | 1.46 |
| 01:48 ET | 400 | 1.465 |
| 01:50 ET | 400 | 1.465 |
| 01:51 ET | 895 | 1.46 |
| 01:53 ET | 790 | 1.46 |
| 01:55 ET | 500 | 1.46 |
| 01:57 ET | 3411 | 1.465 |
| 02:00 ET | 2273 | 1.46 |
| 02:02 ET | 1000 | 1.465 |
| 02:04 ET | 2695 | 1.465 |
| 02:06 ET | 8649 | 1.465 |
| 02:08 ET | 100 | 1.465 |
| 02:09 ET | 3075 | 1.465 |
| 02:11 ET | 1359 | 1.465 |
| 02:15 ET | 300 | 1.46 |
| 02:18 ET | 817 | 1.46 |
| 02:20 ET | 2800 | 1.465 |
| 02:22 ET | 250 | 1.465 |
| 02:26 ET | 100 | 1.46 |
| 02:27 ET | 100 | 1.465 |
| 02:29 ET | 200 | 1.46 |
| 02:31 ET | 400 | 1.465 |
| 02:33 ET | 100 | 1.46 |
| 02:36 ET | 17431 | 1.46 |
| 02:38 ET | 904 | 1.46 |
| 02:40 ET | 1000 | 1.465 |
| 02:42 ET | 500 | 1.4671 |
| 02:44 ET | 300 | 1.46 |
| 02:45 ET | 300 | 1.4646 |
| 02:47 ET | 352 | 1.46 |
| 02:49 ET | 1180 | 1.465 |
| 02:51 ET | 1111 | 1.465 |
| 02:54 ET | 6600 | 1.46 |
| 02:56 ET | 500 | 1.465 |
| 03:02 ET | 1001 | 1.46 |
| 03:03 ET | 4796 | 1.465 |
| 03:05 ET | 500 | 1.465 |
| 03:07 ET | 2595 | 1.465 |
| 03:09 ET | 200 | 1.465 |
| 03:12 ET | 1400 | 1.465 |
| 03:14 ET | 700 | 1.465 |
| 03:16 ET | 58961 | 1.465 |
| 03:18 ET | 4393 | 1.465 |
| 03:20 ET | 988 | 1.465 |
| 03:21 ET | 846 | 1.465 |
| 03:23 ET | 2329 | 1.465 |
| 03:25 ET | 400 | 1.46 |
| 03:27 ET | 700 | 1.46 |
| 03:30 ET | 14674 | 1.465 |
| 03:32 ET | 2127 | 1.465 |
| 03:34 ET | 906 | 1.465 |
| 03:36 ET | 1000 | 1.465 |
| 03:38 ET | 3789 | 1.465 |
| 03:39 ET | 2133 | 1.465 |
| 03:41 ET | 2958 | 1.4618 |
| 03:43 ET | 2406 | 1.465 |
| 03:45 ET | 6483 | 1.465 |
| 03:48 ET | 1065 | 1.465 |
| 03:50 ET | 71871 | 1.475 |
| 03:52 ET | 4793 | 1.47 |
| 03:54 ET | 12039 | 1.47 |
| 03:56 ET | 6143 | 1.47 |
| 03:57 ET | 6582 | 1.47 |
| 03:59 ET | 151766 | 1.47 |
Yesterday
NextPlat Secures Four-Year Extension of OPKO Healthcare E-Commerce Program in China and Agrees to the Expansion of the Program into Japan, from 8:00AM ET on Monday Oct 07, 2024 by Dow Jones
8:00AM ET on Monday Oct 07, 2024 by Dow JonesModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program, from 8:00AM ET on Monday Oct 07, 2024 by Dow Jones
8:00AM ET on Monday Oct 07, 2024 by Dow JonesPress Release: ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program, from 8:00AM ET on Monday Oct 07, 2024 by Dow Jones
8:00AM ET on Monday Oct 07, 2024 by Dow Jones
Sep 26, 2024
DJ OPKO Health Price Target Maintained With a $3.00/Share by HC Wainwright & Co., from 7:08AM ET on Thursday Sep 26, 2024 by Dow Jones
7:08AM ET on Thursday Sep 26, 2024 by Dow Jones
Sep 25, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
OPKO Health Inc | 1.0B | -4.4x | --- |
Pennant Group Inc | 1.1B | 52.6x | -5.49% |
US Physical Therapy Inc | 1.2B | 73.4x | -0.50% |
InnovAge Holding Corp | 725.6M | -34.6x | --- |
Diversified Healthcare Trust | 899.7M | -2.6x | --- |
QDM International Inc | 1.1B | 1,040.4x | --- |
Company Information
OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The Company focuses on leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. Its segments include pharmaceutical and diagnostics. The pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain, Rayaldee product sales and its pharmaceutical research and development. The diagnostics segment primarily consists of point-of-care operations. Its pharmaceutical business features Rayaldee, a United States Food and Drug Administration (FDA) approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage three or four chronic kidney disease (CKD) and vitamin D insufficiency, and Somatrogon (hGH-CTP), a once-weekly human growth hormone injection. Its NGENLA (somatrogon-ghla), is a once-weekly, human growth hormone analog indicated for treatment of pediatric patients aged three years and older.
Contact Information
- Headquarters
- 4400 Biscayne Blvd.MIAMI, FL, United States 33137
- Phone
- 305-575-4181
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Phillip Frost
- President, Vice Chairman of the Board
- Elias Zerhouni
- Vice Chairman of the Board, Chief Technical Officer
- Jane Hsiao
- Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
- Adam Logal
- Chief Executive Officer of OPKO Renal
- Charles Bishop
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.0B |
|---|---|
Revenue (TTM) | $716.4M |
Shares Outstanding | 697.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.65 |
EPS | $-0.33 |
Book Value | $1.80 |
P/E Ratio | -4.4x |
Price/Sales (TTM) | 1.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -37.21% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
